- Home
- RARE vs LFST Comparison
RARE vs LFST Comparison
Compare RARE & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | LFST |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RARE | LFST |
|---|---|---|
| Price | $34.86 | $7.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $85.20 | $9.00 |
| AVG Volume (30 Days) | 1.5M | ★ 2.5M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $630,598,000.00 | ★ $1,367,570,000.00 |
| Revenue This Year | $19.09 | $15.75 |
| Revenue Next Year | $20.62 | $14.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.63 | 13.39 |
| 52 Week Low | $25.81 | $3.74 |
| 52 Week High | $46.50 | $8.30 |
Technical Indicators
Market Signals| Indicator | RARE | LFST |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 73.83 |
| Support Level | $32.64 | $6.75 |
| Resistance Level | $36.81 | $7.05 |
| Average True Range (ATR) | 1.60 | 0.22 |
| MACD | -0.29 | 0.01 |
| Stochastic Oscillator | 28.83 | 91.06 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.